Introduction
In presenting some perspectives on the prevalence of fungal infections in the United Kingdom consideration will not be confined to those mycoses known to be imported from endemic areas outside this country. Data (Ajello, 1970) . If it can be accepted as possible that only 1 in 10 of patients with tinea corporis is referred by a General Practitioner for laboratory examination, and that the corresponding figure for tinea pedis is 1 in 50, then an overall projected total of diagnosed dermatophytoses in the U.K. could be of the order of 220000 patients annually. When added to the self-diagnosed cases, an approximate annual figure of c. 250 000 is obtained.
It cannot be accurately estimated what proportion of this figure represents true infection. From a report published by Holmes and Gentles (1956) Reports of imported infections with other types of mycoses affecting skin, hair or nails are comparatively small. One condition affecting predominantly toe spaces and nails and caused by Hendersonula toruloidea was first described by Gentles and Evans in 1970 . Since that time additional reports by Campbell et al. (1973) and Moore (1978) have established that it is comparatively common in darkskinned subjects. At St John's Hospital for Diseases of the Skin, London, c. 90 cases of this dermatomycosis or the closely related Scytalidium have been seen (Clayton, 1978 (Longbottom and Pepys, 1964) , are often used as diagnostic aids, because patients with allergic aspergillosis usually have low levels of specific IgG antibody to A. fumigatus. By 1972, serodiagnostic tests accounted for 70Y% of the requests for assistance received each year by the MRL. Seventy per cent. of these serological requests were for precipitin tests to A. fumigatus. Up to 10 000 requests for Aspergillus serology were handled annually and although approximately 1300 sera contained antibodies to A. fumigatus, no direct quantitative relationship to clinical disease could be recognized, since details of the patient's condition were seldom provided.
Aspergilloma caused by A. fumigatus and other Aspergillus spp. is less common than allergic aspergillosis. The diagnosis depends primarily on clinical and radiological evidence although the laboratory can assist materially by cultivation of the agent and serodiagnostic testing. It is estimated that 50-80 cases of aspergilloma may be seen each year in the U.K.
Invasive aspergillosis, where the agent becomes established in living tissues, is essentially a disease of severely compromised patients. Laboratory findings are of limited value as diagnostic aids, since cultural and serological findings are frequently negative, even when Aspergillus is later shown to have been present. In the U.K., there is no evidence to suggest that the number of cases exceeds 10-30 per annum. Renal units which previously encountered Aspergillus infections as a post-transplantation complication have more recently reported that they have diminished in importance as a cause of sepsis.
In non-atopic subjects, Aspergillus may colonize diseased airways and cause symptoms associated with chronic inflammatory responses. Aspergillus can be demonstrated in their sputum, and precipitin levels are generally very high. No data are available on the frequency of this 'saprophytic' form of aspergillosis, but its distinction from other forms of aspergillosis is a matter of some relevance in evaluating the choice and response to therapy.
If problems exist in trying to assess numbers of cases of aspergillosis in the U.K., they are much simpler to resolve than those relating to candidiasis. Apart from the more obvious manifestations of the disease as thrush of mucosal surfaces, the spectrum of candidiasis is wide and establishment of a diagnosis is often difficult.
Candidiasis is not commonly reported in this country. For this disease, as for ringworm, the ratio between case numbers (based on available reporting systems and data) and the number of occasions for which anti-Candida therapy is prescribed is extremely low. Estimates of the numbers of infections are therefore very inaccurate.
Invasive candidiasis may be confirmed in 10 to 80 cases per annum, with numbers of clinically significant cases of candidaemia being in the same range. Candida endocarditis may be even less common, with only one to 2 cases per annum. Only by careful evaluation of the patient's condition and the selective and meticulous application of laboratory procedures can a reliable diagnosis be established.
One final mycosis should be mentioned, since its prognosis depends to a large extent on prompt diagnosis and management. This is cryptococcosis, a rare and severe fungal infection affecting the lungs, skin, bones or CNS. In this country, it is best known as cryptococcal meningitis. Between 1962 and 1977, 60 cases of cryptococcosis were reported to the MRL, but proved infections are being recorded at present at the rate of almost one per month. These originate in many parts of the country, and it is clear that the disease is widespread here. In view of the availability of specific laboratory tests it is disappointing to find that cryptococcosis is not more frequently considered and investigated earlier in patients with predisposing factors.
In conclusion, although excellent laboratory facilities exist in this country for the assistance with diagnosis, the true prevalence of fungal infections still remains highly conjectural. Mycoses can be lifethreatening, and in these cases can be eradicated only by rapid and accurate diagnosis, combined with carefully selected and effective courses of management. This is perhaps a good point to restate the absolute need for co-ordination between the physician in charge of the patient and the laboratory undertaking back-up investigations. This, of course, is as true for attempts to gauge incidence of mycoses as it is for their diagnosis and management.
